Back to All Events

Exploring Biotech and Healthcare Innovation with Andrew Cittadine

Mr. Cittadine is the Chief Operating Officer at Monopar Therapeutics, a publicly traded clinical stage biotech company based in Wilmette. He has a successful track record of identifying, founding, and building medical technology businesses from concept to commercialization to acquisition by Fortnute Global 1000 firms, including successful exits to Siemens, Medtronic, and Olympus.